Sponsor Pipeline

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
193
Active Trials
106
Recruiting
11
Phase 3
10
Disease Areas
10
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT05875740
Correlation of Memory CD8+ T Cells With Sepsis Severity and Mortality: a Single-center…
Enrollment increased: 30 -> 80 participants
2026-08-04 NCT06970262
FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients
Recruitment opened
2026-08-02 NCT06503094
CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
overall status: Recruiting → Unknown
2026-08-02 NCT06241274
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
overall status: Recruiting → Unknown
2026-08-02 NCT05998928
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients…
overall status: Recruiting → Unknown
2026-08-02 NCT05883683
Molecular Study and Precision Medicine for Colorectal Cancer
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT05839834
Blood Cell RNA-Based Cancer Detection
overall status: Recruiting → Unknown
2026-08-01 NCT07587684
A Study of IN026 in Participants With Refractory Gout
Recruitment opened
2026-07-31 NCT07699029
Endovascular Treatment for Posterior Circulation Ischemic Stroke Post 1 Day (24 Hours)
Recruitment opened
2026-07-23 NCT07429721
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-06 NCT07749430 A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus… Early Phase 1 Not Yet Recruiting
2026-08-03 NCT07741006 Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors Early Phase 1 Enrolling by Invitation
2026-07-31 NCT07739628 Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine… Enrolling by Invitation
2026-07-27 NCT07728019 Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 4
6
Phase 3
9
Phase 2/3
2
Phase 2
38
Phase 1/2
9
Phase 1
16
Early Phase 1
28
Not specified
85
Active Trials — top 25 of 193
NCT IDTitleConditionStatus
Phase 4
NCT04843982 Immunoinflammatory Regulation of Esketamine in Septic Patients Esketamine Recruiting
NCT07092202 Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC… Leptomeningeal Metastasis Recruiting
NCT05498766 Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients Gastric Cancer Not Yet Recruiting
NCT07189910 Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP Primary Immune Thrombocytopenia (ITP) Not Yet Recruiting
NCT07485764 Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight… Psoriasis Not Yet Recruiting
NCT07567313 Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery… Lung Squamous Cell Carcinoma Stage IV Not Yet Recruiting
Phase 3
NCT06472908 Efficacy and Safety of Colchicine After PCI Coronary Heart Disease Recruiting
NCT07400536 A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy… Locally Advanced Cervical Carcinoma Recruiting
NCT07689630 Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT Graft Versus Host Disease Recruiting
NCT05674539 Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic… Acute Myeloid Leukemia, Adult Enrolling by Invitation
NCT06580223 Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma Multiple Myeloma Not Yet Recruiting
NCT07177443 Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal… Locally Advanced Nasopharyngeal Carcinoma Not Yet Recruiting
NCT07189572 Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After… Otitis Media Not Yet Recruiting
NCT04928807 Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in… Rectal Cancer Active, Not Recruiting
NCT07543978 Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis… Radiotherapy-Induced Oral Mucositis Not Yet Recruiting
Phase 2/3
NCT06785571 The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for… Respiratory Insufficiency Recruiting
NCT06826079 Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With… Gastric Junction Adenocarcinoma Recruiting
Phase 2
NCT06000917 A Study of Neoadjuvant TCHpy(Pyrotinib ,Trastuzumab,Carboplatin and Paclitaxel)for… Breast Cancer Recruiting
NCT06244225 HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)Plus Sintilimab and Donafenib in the… Hepatocellular Carcinoma Recruiting
NCT06234007 Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full… Locally Advanced Rectal Cancer Recruiting
NCT06487429 Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and… Gastric Cancer Recruiting
NCT06491472 Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and… Pancreatic Cancer Recruiting
NCT06542588 Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in… Rectal Cancer Recruiting
NCT06686927 Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of… Primary Immune Thrombocytopenia Recruiting
NCT06802666 Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally… Locally Advanced Rectal Cancer Recruiting
See all 193 active Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials with filters →
Disease Areas
Get alerts when Union Hospital, Tongji Medical College, Huazhong University of Science and Technology's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free